Publications
Dimond ZE, Hefty PS. (2020) Comprehensive genome analysis and comparisons of the swine pathogen, Chlamydia suis reveals unique ORFs and candidate host-specificity factors. Pathog Dis. PMID: 32639528 DOI: 10.1093/femspd/ftaa035
Parker, T.W., Rudeen, A.J., Neufeld, K.L. (2020) Oncogenic Serine 45-Deleted β-Catenin Remains Susceptible to Wnt Stimulation and APC Regulation in Human Colonocytes. Cancers 2020, 12(8), 2114. Special Issue "Targeting Wnt Signaling in Cancer: Opportunities Abound If We Can Avoid the Sword of Damocles"
María Angélica Bravo Núñez, Ibrahim M Sabbarini, Lauren E Eide, Robert L Unckless, Sarah E Zanders. (2020) Atypical meiosis can be adaptive in outcrossed Schizosaccharomyces pombe due to wtf meiotic drivers. eLife 2020;9:e57936 DOI: 10.7554/eLife.57936
Zhang P, Wu X, Gardashova G, Yang Y, Zhang Y, Xu L*, and Zeng Y*. (2020) Molecular and Functional Extracellular Vesicle Analysis using Nanopatterned Microchips Monitors Tumor Progression and Metastasis. Science Translational Medicine 12:eaaz2878 (Featured as cover story). *Correspondence. PMID: 32522804
Liu S, Huang Z, Tang A, Wu X, Aube J, Xu L, Xing C, and Huang Y. (2020) Inhibition of RNA-binding protein HuR reduces glomerulosclerosis in experimental nephritis. Clinical Science (Lond) 2020; 134(12):1433-1448. PMID: 32478392
Lan L, Liu J, Xing M, Smith AR, Wang J, Wu X, Appelman C, Li K, Roy A, Gowthaman R, Karanicolas J, Somoza AD, Wang CCC, Miao Y, De Guzman R, Oakley BR, Neufeld KL, and Xu L. (2020) Identification and Validation of an Aspergillus nidulans Secondary Metabolite Derivative as an Inhibitor of the Musashi-RNA Interaction. Cancers (Basel) 2020; 12(8). (in press) PMID: 32784494
More Publications
Aaron Rudeen (PhD recipient, Neufeld lab) successfully defended his dissertation entitled “The 15-aa Repeat Region of Adenomatous Polyposis Coli: Association with β-catenin and Interplay with Cell Cycle Regulator Topoisomerase IIα” on July 30. Aaron has started a new position with Deciphera Pharmaceuticals, right here in Lawrence, KS.
Matt Ochs (PhD recipient, Lundquist lab) started a position with the life sciences and pharmaceutical product development company Catalent, located in Houston, TX.
Taybor Parker (PhD recipient, Neufeld lab) started a position with Catalent, Inc. in Kansas City, MO.
Clint Rice (IRACDA postdoc with Rob Ward and Rob Unckless) accepted a position at Catalent, Inc. in Madison Wisconsin. Congratulations Clint!